The Current Landscape of Diabetes Trials
The United States runs hundreds of active diabetes trials at any given time, spread across major research centers like the Joslin Diabetes Center in Boston, UCLA Health, the University of Florida, and Yale. These studies fall into three broad buckets: prevention trials for people at risk, treatment trials for those already diagnosed, and technology trials testing devices like automated insulin delivery systems.
For type 2 diabetes, the focus has shifted toward comparative effectiveness. The GRADE study, one of the largest of its kind, compared commonly used glucose-lowering medications combined with metformin to see which worked best over time. Results from studies like this shape how doctors prescribe, which matters if you have been on the same medication for years without seeing improvement.
For type 1 diabetes, prevention is the buzzword. TrialNet's Pathway to Prevention program screens relatives of people with type 1 diabetes to identify early autoantibodies, and new studies are testing drugs like teplizumab and baricitinib to delay or slow disease progression. A platform trial comparing teplizumab with anti-thymocyte globulin is currently recruiting at multiple US sites, with follow-up visits scheduled every six months over several years.
What you may not realize is that most trials cover the cost of the investigational treatment and study-related care. That does not mean everything is free, but the research sponsor typically handles the intervention, lab work, and study visits. Travel reimbursement and compensation for time vary widely, so it pays to ask upfront.
What to Consider Before You Enroll
Eligibility is the first wall most people hit. Type 1 trials often require a specific disease stage or a narrow window after diagnosis. If you have had type 1 diabetes for ten years, a study designed for newly diagnosed patients will not accept you no matter how motivated you are. Type 2 trials tend to be more flexible, but they still screen for factors like kidney function, heart health, and current medications.
Time commitment is the second consideration. A Phase 3 study can run one to four years, with clinic visits every few months and phone check-ins in between. The teplizumab platform trial, for instance, requires multiple in-person visits in year one, then six-month follow-ups afterward. That is a real lifestyle adjustment, especially if the nearest study site is a few hours away.
The third factor is understanding what phase you are entering. Phase 1 trials test safety in small groups and are the most intensive. Phase 2 trials look at effectiveness in larger groups. Phase 3 trials compare the new treatment against standard care across diverse populations and are typically the closest to FDA approval. A Phase 3 study like the AMAZE 2 trial for weight management in type 2 diabetes gives you access to a treatment that could be on the market within a couple of years.
Types of Trials and What They Offer
| Trial Category | Example Study | Typical Duration | Best For | Advantages | Challenges |
|---|
| Prevention (Type 1) | Teplizumab vs. ATG platform trial | 3-4 years | Relatives with autoantibodies | Potential to delay onset | Frequent follow-up visits |
| Medication Comparison | GRADE study | Several years | Adults on metformin | Real-world medication insights | Long-term commitment |
| Weight Management | AMAZE 2 (NNC0487-0111) | 1-2 years | Adults with excess weight and T2D | Weekly injection, weight loss focus | Placebo possibility |
| Technology | Automated insulin delivery trials | 6-18 months | Pump or basal-bolus users | Access to next-gen devices | Device training required |
| Hospital Care | Oral agents vs. basal-bolus therapy | Short-term | Hospitalized patients | Better inpatient glucose control | Limited enrollment windows |
Compensation in US diabetes trials typically falls into four categories: reimbursement for travel and expenses, payment for time and inconvenience, completion bonuses, and referral incentives. Phase 1 studies often pay around $10 to $20 per hour, while longer Phase 2 and Phase 3 studies can offer several hundred to a few thousand dollars depending on visit frequency and duration. The UVA Center for Diabetes Technology, for example, has offered completion payments plus separate reimbursement for clinic visits. Online research platforms also pay for surveys and virtual interviews, though these are short engagements with lower total payouts.
How to Find and Evaluate a Trial
Start with ClinicalTrials.gov, the NIH database that lists studies across the country. Use the advanced search to filter by condition, status, and location. Look for studies marked "Recruiting" and check the eligibility criteria carefully before contacting the coordinator. You can also search for "diabetes clinical trials near me" to find local academic medical centers, many of which maintain their own trial listings.
TrialNet is the go-to resource for type 1 diabetes prevention. Their Pathway to Prevention screening is open to family members of people with type 1 diabetes, and positive autoantibody results open the door to prevention studies. University research portals, like the one at UCLA, list active diabetes trials with direct contact information for coordinators.
Before you commit, ask these questions: Who covers the investigational drug and study procedures? What does the visit schedule actually look like? Will my regular doctor be kept informed? What happens if I need to withdraw early? Is there compensation for travel or time, and how is it structured?
A Realistic Look at the Experience
Marcus from Columbus, Ohio, enrolled in a type 2 medication study after his A1C stayed stuck around 8 percent despite two different drug combinations. The trial gave him access to a weekly injectable he could not otherwise afford, and the research team monitored his glucose more closely than his routine care ever had. He stayed in the study for eighteen months, and while the time commitment was real, the structured follow-up helped him build habits that outlasted the trial.
Sarah from Phoenix took a different route. Her daughter was diagnosed with type 1 diabetes at age nine, and the whole family enrolled in TrialNet screening. The daughter tested positive for multiple autoantibodies, which qualified her for a prevention study. For Sarah, the value was not financial, it was knowing they had options years before symptoms appeared.
Not every story is smooth. Some participants report that placebo assignment is hard to accept, especially when you hoped for the active treatment. Others find the travel burden heavier than expected, particularly in rural states where the nearest research site may be two hundred miles away. A few studies close early, like the hospital-based oral antidiabetic trial that was terminated in April 2026 after recruitment stalled. That is part of the reality, and coordinators should be transparent about these risks during the consent process.
Making the Decision That Fits Your Life
A clinical trial is not a magic bullet, but for many Americans it is a structured way to access newer treatments, receive closer monitoring, and contribute to research that will shape diabetes care for the next generation. The key is matching the trial to your situation, your schedule, and your treatment goals.
Start by checking ClinicalTrials.gov and TrialNet, then reach out to a study coordinator at a nearby academic medical center. Bring your medication list, your recent lab results, and a list of questions. The coordinator will walk you through eligibility, logistics, and what the sponsor covers.
Whether you are newly diagnosed, living with diabetes for decades, or a family member who wants to help prevent it, there is likely a study designed for someone like you. The first step is just asking.
研究の知恵